TB Research

Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.

Olanrewaju Oladimeji, Victor Abiola Adepoju, Felix Emeka Anyiam, James Emmanuel San, Babatunde A. Odugbemi, Francis Leonard Mpotte Hyera, Sanni Yaya, Maureen Nokuthula Sibiya, et al. (10 authors)

Zenodo (CERN European Organization for Nuclear Research) · 2020-12

Abstract

<strong>Abstract<br> Objective: </strong>The Lagos State Tuberculosis, Buruli Ulcer, and Leprosy Control Program<br> (LSTBLCP) started engaging private hospitals under the Public-Private Mix (PPM)<br> Program in 2008. The study aimed to evaluate the trend and predictors of successful<br> Tuberculosis (TB) treatment outcomes of patients managed across these private health<br> facilities between 2010-2016 in Lagos, Nigeria. <strong>Method: </strong>Retrospective review of TB treatment register and treatment cards of patients<br> commenced on TB treatment between January 2010 and December 2016 in 36 private<br> health facilities engaged by the LSTBLCP. Between December 2016 and February<br> 2017, data were collected and entered into Microsoft Excel by trained data entry clerks.<br> The analysis was done using SPSS software. Independent predictors of successful<br> treatment outcomes were determined using multivariate analysis at the statistical<br> significance of p&amp;lt;0.05 and 95% confidence interval. <strong>Results: </strong>A total of 1660 records of TB patients were reviewed. 1535 (92.47%)<br> commenced treatment, while 1337 (87.10%) of all records had documented treatment<br> outcomes. Of the 1337 patients with outcomes, 1044 (78.09%) had a successful<br> treatment outcome, and 293 (21.91%) had an unsuccessful outcome . Majority were<br> male, 980 (59.04%), Human Immunodeficiency Virus (HIV) negative status, 1295<br> (80.24%) , diagnosed with smear, 1141 (73.14%), treated in private not-for-profit<br> (PNFP) hospital, 1097 (66.08%), treated for TB between 2014-2016 (18.96%-19.52%).<br> In multivariate analysis, age&amp;gt;20years (aOR=0.26, p=0.001), receiving TB treatment in<br> 2013 (aOR=0.39, p=0.001), having genexpert for TB diagnose(aOR=0.26, p=0.031) and<br> being HIV positive (aOR=0.37, p=0.001) significantly reduced likelihood of successful<br> treatment outcome. The site of TB, being on ART or CPT, were confounding<br> determinants of successful treatment outcomes as they became non-significant at the<br> multivariate analysis level.

MeSH terms

  • Tuberculosis
  • Drug
  • Medicine
  • Environmental health
  • Health facility